Essi Myrsky, PhD

Essi Myrsky

PhD

Finland

Main Specialties: Allergy & Immunology, Biochemical Genetics, Biology, Biotechnology, Blood Banking - Transfusion Medicine, Chemical Pathology, Chemistry, Clinical & Laboratory Immunology, Infectious Disease, Internal Medicine-Pediatrics, Medical Genetics, Medical Microbiology, Statistics

Essi Myrsky, PhD

Essi Myrsky

PhD

Publications

5Publications

46Reads

2Profile Views

RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.

J Mol Med (Berl) 2012 Jul 6;90(7):817-26. Epub 2012 Jan 6.

Pediatric Research Center, University of Tampere, Tampere University Hospital, Finn-Medi 3, School of Medicine 33014, University of Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-011-0853-0DOI Listing
July 2012
13 Reads
5.107 Impact Factor

Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Cell Mol Life Sci 2009 Oct 13;66(20):3375-85. Epub 2009 Aug 13.

Pediatric Research Center, Medical School, University of Tampere, Tampere, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-009-0116-1DOI Listing
October 2009
9 Reads
5.808 Impact Factor

Altered small-bowel mucosal vascular network in untreated coeliac disease.

Scand J Gastroenterol 2009 ;44(2):162-7

Paediatric Research Centre, Medical School, University of Tampere.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520802400875DOI Listing
June 2009
10 Reads
2.329 Impact Factor

Membrane potential and endocytic activity control disintegration of cell-cell adhesion and cell fusion in vinculin-injected MDBK cells.

J Cell Physiol 2004 Sep;200(3):417-27

Biocenter Oulu and the Department of Pathology, University of Oulu, University of Oulu, Finland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcp.20024
Publisher Site
http://dx.doi.org/10.1002/jcp.20024DOI Listing
September 2004
3 Reads
3.839 Impact Factor